MétaCan
Menu
Back to cohort
Record W4221042811 · doi:10.1111/all.15275

Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air<sup>®</sup> real‐world data

2022· article· en· W4221042811 on OpenAlexaff
Bernardo Sousa‐Pinto, Ana Sá‐Sousa, Rafael José Vieira, Rita Amaral, Ludger Klimek, Josep M. Antó, Oliver Pfaar, Anna Bedbrook, Violeta Kvedarienė, Maria Teresa Ventura, Ignacio J. Ansotegui, Karl‐Christian Bergmann, Luisa Brussino, Giorgio Walter Canonica, Victória Cardona, Pedro Martins, Thomas B. Casale, Lorenzo Cecchi, Tomás Chivato, Derek K. Chu, Cemal Cingi, Elı́sio Costa, Álvaro A. Cruz, Giulia De Feo, Philippe Devillier, Wytske J. Fokkens, Mina Gaga, Bilun Gemicioğlu, Tari Haahtela, Juan Carlos Ivancevich, Zhanat Ispayeva, Marek Jutel, Piotr Kuna, Ігор Петрович Кайдашев, Helga Kraxner, Désirée Larenas‐Linnemann, Daniel Laune, Brian J. Lipworth, Renaud Louis, Μichael Μakris, Riccardo Monti, Mário Morais‐Almeida, Ralph Mösges, Joaquim Mullol, Mikaëla Odemyr, Yoshitaka Okamoto, Nikolaos G. Papadopoulos, Vincenzo Patella, N. Pham‐Thi, Frederico S. Regateiro, Sietze Reitsma, Philip W. Rouadi, Bolesław Samoliński, Milan Sova, Ana Todo‐Bom, Luís Taborda‐Barata, Peter Valentin Tomazic, Sanna Toppila‐Salmi, J. Sastre, Ioanna Tsiligianni, Arūnas Valiulis, Olivier Vandenplas, Dana Wallace, Susan Waserman, Arzu Yorgancıoğlu, Mihaela Zidarn, Torsten Zuberbier, João Fonseca, Jean Bousquet

Bibliographic record

VenueAllergy · 2022
Typearticle
Languageen
FieldMedicine
TopicAllergic Rhinitis and Sensitization
Canadian institutionsMcMaster UniversityMcMaster University Medical CentreImpact
FundersEIT HealthMylanSanofiAstraZeneca
KeywordsMedicineAllergyDermatologyPediatricsImmunology

Abstract

fetched live from OpenAlex

Abstract Background Co‐medication is common among patients with allergic rhinitis (AR), but its dimension and patterns are unknown. This is particularly relevant since AR is understood differently across European countries, as reflected by rhinitis‐related search patterns in Google Trends. This study aims to assess AR co‐medication and its regional patterns in Europe, using real‐world data. Methods We analysed 2015–2020 MASK‐air ® European data. We compared days under no medication, monotherapy and co‐medication using the visual analogue scale (VAS) levels for overall allergic symptoms (‘VAS Global Symptoms’) and impact of AR on work. We assessed the monthly use of different medication schemes, performing separate analyses by region (defined geographically or by Google Trends patterns). We estimated the average number of different drugs reported per patient within 1 year. Results We analysed 222,024 days (13,122 users), including 63,887 days (28.8%) under monotherapy and 38,315 (17.3%) under co‐medication. The median ‘VAS Global Symptoms’ was 7 for no medication days, 14 for monotherapy and 21 for co‐medication ( p &lt; .001). Medication use peaked during the spring, with similar patterns across different European regions (defined geographically or by Google Trends). Oral H 1 ‐antihistamines were the most common medication in single and co‐medication. Each patient reported using an annual average of 2.7 drugs, with 80% reporting two or more. Conclusions Allergic rhinitis medication patterns are similar across European regions. One third of treatment days involved co‐medication. These findings suggest that patients treat themselves according to their symptoms (irrespective of how they understand AR) and that co‐medication use is driven by symptom severity.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.092
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.083
GPT teacher head0.318
Teacher spread0.235 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations61
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueAllergySame topicAllergic Rhinitis and SensitizationFrench-language works237,207